VCELL HEALTHCARE

Vcell Healthcare is a developer and manufacturer of monoclonal antibody biosimilar products.

#SimilarOrganizations #More

VCELL HEALTHCARE

Industry:
Biotechnology Manufacturing Pharmaceutical

Founded:
2019-01-01

Address:
Shanghai, Shanghai, China

Country:
China

Status:
Active


Similar Organizations

advanced-chromatography-technologies-logo

Advanced Chromatography Technologies

Advanced Chromatography Technologies develops and manufactures HPLC columns and related products.

fortune-healthcare-logo

Fortune Healthcare

FortuneHealthcare.in is a pharmaceutical company manufacturing premium health care products.

glyconex-logo

GlycoNex

GlycoNex develops and licenses anti-cancer monoclonal antibodies.

lucaspye-bio-logo

LucasPye BIO

A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.

More informations about "Vcell Healthcare"

Vcell Healthcare - Crunchbase Company Profile & Funding

Vcell Healthcare is a developer and manufacturer of monoclonal antibody biosimilar products. Where is Vcell Healthcare's headquarters? Vcell Healthcare is located in Shanghai, Shanghai, …See details»

Celltrion and Nan Fung Group to establish Vcell Healthcare …

Jul 19, 2019 · Vcell Healthcare Limited will obtain the exclusive rights in m ainland China to develop, manufacture and commercialize three US FDA and EMA approved biosimilar …See details»

Celltrion and Nan Fung Group to establish Vcell Healthcare

Jul 19, 2019 · Vcell Healthcare Limited will obtain the exclusive rights in m ainland China to develop, manufacture and commercialize three US FDA and EMA approved biosimilar …See details»

Celltrion sets up Chinese joint venture - biopharma …

Jul 30, 2019 · As part of the joint venture, Celltrion will provide Vcell with exclusive rights in mainland China to its three US and European Union (EU) approved biosimilars: CT-P13 (Remsima), CT-P10 (Truxima), and CT-P6 …See details»

Celltrion And Nan Fung Group To Establish Vcell Healthcare …

Jul 18, 2019 · Vcell Healthcare Limited will obtain the exclusive rights in mainland China to develop, manufacture and commercialize three US FDA and EMA approved biosimilar …See details»

Celltrion and Nan Fung Group to establish Vcell Healthcare …

Vcell Healthcare Limited will obtain the exclusive rights in mainland China to develop, manufacture and commercialize three US FDA and EMA approved biosimilar products from …See details»

Vcell Healthcare - Products, Competitors, Financials, Employees ...

Celltrion introduced Vcell Healthcare as a joint venture established in 2019 by Celltrion Hong Kong and Nan Fung Group, a Hong Kong-based multinational company. Since Nan Fung …See details»

Celltrion and Nan Fung Group form joint venture for copy …

Aug 2, 2019 · Vcell Healthcare will obtain the exclusive rights in mainland China to develop, manufacture and commercialize three of Celltrion’s biosimilars, which are approved by both …See details»

Vcell Healthcare - Crunchbase

Vcell Healthcare is a developer and manufacturer of monoclonal antibody biosimilar products.See details»

Celltrion, Nan Fung Group form JV to market Biosimilars in China

Vcell Healthcare Limited will obtain the exclusive rights in mainland China to develop, manufacture and commercialize three US FDA and EMA approved biosimilar products from …See details»

Hong Kong developer Nan Fung launches biosimilar joint venture

Jul 19, 2019 · Shanghai-based Vcell Healthcare Limited, set up in collaboration with South Korean biopharmaceutical company Celltrion, will own the rights to develop, manufacture and …See details»

Biosimilars JV set up by Celltrion and Nan Fung Group

Jul 19, 2019 · South Korea’s Celltrion (Kosdaq: 068270) and privately-held Hong Kong-based Nan Fung Group have established Vcell Healthcare as a joint venture company between both …See details»

Vcell Healthcare Ltd. - BioCentury Company Profiles - BCIQ

Vcell Healthcare Ltd. - BioCentury Company Profiles for the biopharma industrySee details»

Celltrion Forms Joint Venture to Sell 3 Biosimilars in China

Jul 20, 2019 · Vcell will obtain the exclusive rights in mainland China to develop, manufacture and commercialize 3 biosimilar products from Celltrion: CT-P13 (Remsima, Inflectra, an infliximab …See details»

CÔNG TY CỔ PHẦN CHỨNG NHẬN VÀ GIÁM ĐỊNH QUỐC TẾ …

Dịch vụ chăm sóc sức khỏe và các dịch vụ xã hội khác Health and social work 75: Thú y/ Veterinary activities 86: Các hoạt động liên quan đến sức khỏe con người/ Human health …See details»

VCell- Modeling & Analysis Software – Virtual Cell Modeling

VCell (Virtual Cell) is a comprehensive platform for modeling cell biological systems that is built on a central database and disseminated as a web application.See details»

Công ty Cổ phần Vật tư Y tế Hà Nội

Công ty Cổ phần Vật tư Y tế Hà Nội (HMP) là đơn vị chuyên cung cấp các sản phẩm cho các đối tác tại các trung tâm kinh doanh dược, thiết bị y tế cũng như cung cấp trực tiếp cho các cơ sở …See details»

Celltrion and Nan Fung Group to establish Vcell Healthcare …

Jul 23, 2019 · Vcell Healthcare Limited will obtain the exclusive rights in m ainland China to develop, manufacture and commercialize three US FDA and EMA approved biosimilar …See details»

The first-ever global oral health conference highlights universal ...

2 days ago · Delegations from over 110 countries are coming together to produce national roadmaps and negotiate a joint declaration on oral health at the first-ever global oral health …See details»

Phường Định Công - Cổng thông tin điện tử Quận Hoàng Mai

Aug 19, 2024 · Hòa chung không khí tưng bừng, phấn khởi của hàng triệu học sinh trong cả nước đón chào năm học mới. Sáng ngày 05 tháng 9 năm 2024, thầy và trò trường Tiểu học …See details»

linkstock.net © 2022. All rights reserved